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A number of qualifications can lead to employment in
Clinical Engineering. A Clinical Engineer (CE) can be an
Engineer who has completed an accredited Engineering
degree with three years of relevant experience, an Engi-
neering Associate who holds an Advanced Diploma in
technical or nursing fields, or an Engineering Technologist
who has completed a recognised Science/Technology
degree that can work within clinics and/or provide spec-
ialised services for clinics [1–4]. One generic skill of the
CE is the understanding and interpretation of physical and
physiological measurements and the immediate recognition
of physiological waveforms displayed on a bedside monitor
and indentify uncharacteristic behaviour of these signals.
The CE is well aware of the uncertainty of clinical mea-
surements and with the advancement of technology and
medical IT, one can considers the history of individuals
and incorporate this information into the variance of the
measurements. As an Associate Editor, it is not uncommon
to see manuscripts sent in with measurements presented
with over six significant figures for large scale values, the
default of the analytical package, when, at best, the error
allows for no decimal place. This carelessness can mislead
readers about the accuracy of the methodology and/or
analysis. As Engineers and Scientists, we need to be vigi-
lant of how measurements are used and consider that var-
iability of a measured quantity not just its mean.
The CE is trained to consider both instrumentation
(technical) variance and biological (physiological) variance
in measurements. Some aspects to consider are:
(i) in instrumentation, the calibration of a parameter
is acceptable within a narrow 99 % confidence
interval (CI);
(ii) in Biology and Physiology, the acceptable range
is nominally the 95 % CI; and
(iii) all measurements should be within the range of
biological and physiological expectations.
Uncertainties are physical limitations of the accuracy of
measuring devices. Accuracy is the proximity of the
measurement to the true value or the reliability of the
measurement within an uncertainty. Each device has the
precision listed in the specification and precision, the
repeatability, or reproducibility of the measurement? The
precision of a device should be seen in the number of
significant digits the device displays. It would be expected
that the more significant digits that a device displays, the
more precise the instrument. However, this cannot auto-
matically be assumed to be true and should be tested.
A critical consideration of the uncertainty in measure-
ment is that the biological or physiological quantity being
measured has an uncertainty that is not dependent on the
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device’s measurement limitation. This uncertainty depends
upon the distribution of the repeated measurements of the
subject being monitored. The accuracy is the device’s
ability to measure the TRUE value of the physical entity it
is measuring. In this editorial we consider three frequently
monitored physiological measurements: the Electrocar-
diogram (ECG); the Blood Pressure; and Pulse Oximetery.
Examine their uncertainty in measurement and conclude
with a general application of uncertainty to clinical
measurements.
An ECG monitor can measure body surface potentials
down to 0.2 mV with a time resolution of 1 ms, but only
displays the waveform to 1 cm = 1 mV resolution; it
records the derived and averaged Heart Rate (HR) to ±1
beat per minute (bpm) with a running average computed
[5]. The accuracy allows the HR parameter of the device to
go to three significant places. Here, we see that the device
displaying this measurement was designed for the purpose
for which it is used. No clinicians will change their course
of action just because the HR has gone from 75.432 to 75.
433.
With the advent of Heart Rate Variability (HRV), one
can use the accuracy of the ECG monitor to determine
HRV with a clinical acceptable mean of 141 ± 39 ms
(mean and standard deviation) for a healthy subject. This
equates to the 95 % confidence of short term variance of
time between two consecutive heart beats in healthy adults
being 104 ms [6–8]. Therefore, if we were to take the
average HR of the 75 bpm and apply the 95 % CI based on
average healthy HRV range of 65–85 bpm this make the
average HR of healthy individuals 75 ± 10 bpm. Surely,
this is a more accurate and reproducible representation of
the true HR, where the device accuracy is used to derive
HRV, which is the uncertainty of this measurement that is
defined by one individual’s physiological variance and this
variance adds to the therapeutic value of the ECG.
Another common and essential clinical measurement is
the assessment of blood pressure. A bedside, physiological,
non-invasive monitoring device measuring the cuff blood
pressure may be a purely mechanical (pneumatic) device or
an automated electromechanical device. The basic
mechanical device has variances purely based on the
physical size of the instrument, where a small dial that
measures the pressure has a direct influence on the reso-
lution of the measurement. This measurement is not only
affected by instrumentation uncertainty but is also depen-
dent on subjective uncertainty. There are spurious errors of
the observer hearing the onset and decay of the Korotkoff
sounds or observing the start and end of oscillations on the
needle of the aneroid dial. There is also variance in the
design control of the device. The instrumentation uncer-
tainty is governed by AS ES 1060.3:2004 (manual) and
AS/ANS3200.2.30:2001 (automated), where the accuracy
of data is stated as a maximum of ±5 mmHg, with a
standard deviation of 8 mmHg over 20 repeated measure-
ments [9, 10]. This equates to allowing a 95 % CI of
uncertainty in the accuracy of the measurement to under or
over estimating the reading by the mean of 5 ± 15 mmHg
and the pressures are reported with the accuracy of single
units. In the lower range case of this uncertainty, a systolic
pressure of 130 mmHg can have a 95 % CI range of 120 to
140 mmHg. This makes the systolic pressure reading with
a 95 % CI 130 ± 10 mmHg, the instrumentation displays
measures down to 1 mmHg and the uncertainty can be up
to 20 mmHg (the upper range of the 95 % CI uncertainty).
Clinicians should be aware of this wide uncertainty and re-
consider whether cuff pressure changes say below
10 mmHg are an actual change in pressure.
The more accurate method of measuring blood pressure
is the invasive or direct blood pressure device. According
to AS/NZS 3200.2.34:1996, the approval and test specifi-
cation of Medical electrical equipment, the particular
requirements for safety of direct blood-pressure monitoring
equipment requires an operating range for the pressure
transducer to be within a static pressure of 4,000 and
-400 mmHg. This standard states that the dynamic pres-
sure at 1 Hz that is reflected in manufacturer specification
that the uncertainty of the pressure measurement, be within
4 mmHg, [5]. This means the 95 % CI for a systolic
pressure of 130 mmHg is 126–134 mmHg, but as in HR
case, we need to account for the variability of beat to beat
systolic pressure and this variance could be up to 30 % and
is dependent on the volumetric state of an anaesthetised or
subdued patient that varies from 6 to 18 % [11, 12]. This
makes the physiological variance with a 95 % CI range
from 122–138 to 107–153 mmHg depending on volumetric
state. It is the range of this variance that gives volumetric
state of the patient and the current devices average this out.
It is essential here that we are all aware of, and have
accounted for, the dynamics of the catheter-transducer
system and have the system critically damped and does not
over or under estimate the pressure.
Pulse Oxymetery has become the standard, most com-
monly used, clinical performance indicator of both the
circulatory and respiratory systems. The Oxymeter detects
the deflected/observed light and analyses the wavelengths
of oxygenated and de-oxygenated blood to derive a satu-
ration percentage. This saturation is then mapped to partial
pressure of Oxygen in the peripheral arteries. At arterial
oxygen saturations above 90 %, the variability between
true and recorded saturation is 5 % and, therefore, the
95 % CI for a saturation reading of 95 % is 90–100 %.
Below 90 % saturation, when the attention of the clinician
is required, the 95 % CI goes up by 10 % [13]. This range
is where a small drop in the saturation levels can make a
critical difference in terms of patient management of
468 Australas Phys Eng Sci Med (2014) 37:467–470
123
hypoxia due to the characteristics of the saturation curve
and delivering O2 to the tissues. Also, other factors can
alter the accuracy of Pulse Oxymetery, such as skin pig-
mentation, location of the sensor, and ambient light. The
more reliable way to measure partial pressures of gas in
blood is to take blood samples.
The above examples of ECG, the Blood Pressure and the
Pulse Oxymetery are the basic and commonly used clinical
measured parameters, These parameters are time variable
and the technique for measurement, as illustrated, intro-
duces variability and bias, and all devices have their cali-
bration issues. So we expect a measurement to be of the
form.
Y measured ¼ Y true þ Delta technique þ U device
where the measurement (Y_measured) is the sum of the
true measurement (Y_true), the error introduced by the
technique of measurement and the uncertainty specific to
the device (? U_device). Typically U_device is bounded,
typically determined by the calibration. The Delta_tech-
nique is typically modelled as a random variable, with a
bias and a variance error, which is independent of the
device but dependent on biology/physiology, and can be
considered stationary over a short period of measurement.
The length of this period can be within weeks for healthy
individuals or within minutes for critically cared
individuals.
Then we re-consider the above equation as time variant.
Y measured tð Þ ¼ T sð Þ y true tð Þ þ Delta technique
þ U device
where T(s) has history of individuals and T(s){-1} may
not exist in general, and hence the sampling period and
sampling interval becomes very important. In which case
we have a Least Squares approximation or algorithmic
error in the recovery of the y_true. We report on a
Y_estimate based on Y_measured, and the error between
y_true and y_estimate includes all the errors of technique,
device, but also the inclusion of measurement algorithm
errors [14].
The accuracy of a device is its ability to measure the true
level of the physiological parameter. The repeatability of
accuracy is a measure of its ability to indicate the same
value of the measured quantity with repeated measure-
ments. With scientific instruments, poor repeatability can be
a sign of poor accuracy, but with medical devices, as
illustrated above, poor repeatability is also a sign of wide
variance that is inherent in biological systems. Here, the two
terms of accuracy and uncertainty are independent and one
cannot be replaced by the other. To achieve better mea-
surement, we aim to be more accurate with less uncer-
tainty. Here, the CE ensures, with the annual preventative
maintenance schedule, that the measurements of the device
are well within the specifications of the manufacturer. The
manufacturer’s design control processes produce the pre-
cision within the device that has the instrumentation
uncertainty of the measurement well within the physiolog-
ical variance. Accuracy is measured against a gold standard
of measurement and the accuracy of a particular instrument
is how close the instrument indicates the true value of the
quantity. Medical devices have a high accuracy and
repeatability but also have a high physiological variance
that is dependent on the physiological state of the individual
patient. This variance should be indicated by the measuring
devices so that it can be properly interpreted and understood
by the clinicians.
The CE faces a number of uncertainties in clinical
measurement. The CE has the skill, along with the cli-
nicians, to understand those variances and uncertainties.
The CE can also respond appropriately to the variance in
measurement and technically maintain the certainty in the
measurements of all devices. This skill is just one of the
many skills that the CE professional must develop, and a
vital service that is offered to the Health Care Industry
that is not offered by third party services on a day-to-day
basis.
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